Recent content by Kestrel

Also. . . . "Boston, MA - August 12, 2008 - Follica Inc., a privately held developer of novel therapies for androgenetic alopecia and other hair follicle disorders, today announced an $11 million Series B financing round. Polaris Venture Partners led the financing and existing investors...

This excerpt from a question & answer session seems to suggest that DHT susceptibility in newly generated HF may not be much of a problem, or a problem at all. It is cut from http://www.xconomy.com/boston/2008/01/0 ... reatment/2 David Steinberg claims to be with Follica. Erik Sebesta...

Thanks for the follow-up. At worst, even if the new follicles do succumb to DHT over time, as you suggest, minoxidil and/or Propecia may have enough of a mitigating effect. Also, you have an infinite supply of genetically immune follicles from the back and sides of the head. Maybe if the...

Hi folks, I just discovered this forum after having watched the Cotsarelis clip from the Today Show. Hopefully, the collaborative efforts here will yield an off-the-shelf formulation and procedure with some efficacy. I read through the patent, but not having training in the biological...